glutathione and parkinson's disease 2019 Revamping therapy using PLGA-based drug delivery systems Targeting the Cysteine Redox Proteome

Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder Signal Transduction and Targeted Therapy Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation Parkinson's Disease: Current Treatment Modalities and Emerging Therapies PMC Parkinson's disease and glucose metabolism impairment Translational Neurodegeneration Springer Nature Link Parkinson's Disease: Cells Succumbing to Lifelong Dopamine Related Oxidative Stress and Other Bioenergetic Challenges

SKU: 4778460031 · From reganhouse.co.nz